This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/chebi/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB07297/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07297
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07297 n7:DB07297
dcterms:title
5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
adms:identifier
n10:21865411 n11:DB07297 n12:40432 n13:99443768 n14:979 n15:17756743
n5:IUPAC-Name
n6:271B5D87-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5D8D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5D8C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5D89-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5D8A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5D8B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5D85-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5D86-363D-11E5-9242-09173F13E4C5 n6:271B5D83-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5D84-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5D93-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5D94-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5D8E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5D8F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5D91-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5D90-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5D92-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5D99-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5D9B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5D9C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5D98-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5D97-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5D9A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5D88-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5D95-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5D96-363D-11E5-9242-09173F13E4C5